SARS-CoV-2 与其他呼吸道病原体的合并感染率。
Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens.
机构信息
Department of Emergency Medicine, Stanford University School of Medicine, Stanford, California.
Department of Pathology and Medicine, Stanford University School of Medicine, Stanford, California.
出版信息
JAMA. 2020 May 26;323(20):2085-2086. doi: 10.1001/jama.2020.6266.
Abstract
This study describes the prevalence of SARS-CoV-2 co-infection with noncoronavirus respiratory pathogens in a sample of symptomatic patients undergoing PCR testing in March 2020.
摘要
本研究描述了在 2020 年 3 月接受 PCR 检测的有症状患者样本中，SARS-CoV-2 与非冠状病毒呼吸道病原体合并感染的流行情况。
相似文献
1
Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens.SARS-CoV-2 与其他呼吸道病原体的合并感染率。
JAMA. 2020 May 26;323(20):2085-2086. doi: 10.1001/jama.2020.6266.
2
Coinfection of SARS-CoV-2 and multiple respiratory pathogens in children.儿童中新型冠状病毒（SARS-CoV-2）与多种呼吸道病原体的合并感染
Clin Chem Lab Med. 2020 Jun 25;58(7):1160-1161. doi: 10.1515/cclm-2020-0434.
3
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.COVID-19 住院患者的细菌和真菌感染：英国二级保健机构中的回顾性队列研究。
Clin Microbiol Infect. 2020 Oct;26(10):1395-1399. doi: 10.1016/j.cmi.2020.06.025. Epub 2020 Jun 27.
4
Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients.感染患者中SARS-CoV-2与多种常见呼吸道病原体的合并感染。
Sci China Life Sci. 2020 Apr;63(4):606-609. doi: 10.1007/s11427-020-1668-5. Epub 2020 Mar 5.
5
[Investigation of pathogenic agents causing acute respiratory tract infections in pediatric patients in a children's hospital assigned for case screening in Beijing during the outbreak of COVID-19].[新型冠状病毒肺炎疫情期间北京某儿童医院儿科急性呼吸道感染病原筛查]
Zhonghua Er Ke Za Zhi. 2020 Aug 2;58(8):635-639. doi: 10.3760/cma.j.cn112140-20200426-00437.
6
Chilblains is a common cutaneous finding during the COVID-19 pandemic: A retrospective nationwide study from France.冻疮是新冠疫情期间常见的皮肤表现：一项来自法国的全国性回顾性研究。
J Am Acad Dermatol. 2020 Aug;83(2):667-670. doi: 10.1016/j.jaad.2020.04.161. Epub 2020 May 4.
7
Acral cutaneous lesions in the time of COVID-19.2019冠状病毒病时期的肢端皮肤病变
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e346-e347. doi: 10.1111/jdv.16533. Epub 2020 May 27.
8
Effect of Gastrointestinal Symptoms in Patients With COVID-19.新型冠状病毒肺炎患者胃肠道症状的影响
Gastroenterology. 2020 Jun;158(8):2294-2297. doi: 10.1053/j.gastro.2020.03.020. Epub 2020 Mar 19.
9
Two cases of skin manifestations prior to the onset of COVID-19 respiratory symptoms.两例在COVID-19呼吸道症状出现之前出现皮肤表现的病例。
Int J Dermatol. 2020 Dec;59(12):1541-1542. doi: 10.1111/ijd.15247. Epub 2020 Oct 20.
10
COVID-19 and mycoplasma pneumoniae coinfection.新型冠状病毒肺炎与支原体肺炎合并感染
Am J Hematol. 2020 Jun;95(6):723-724. doi: 10.1002/ajh.25785. Epub 2020 Apr 3.
引用本文的文献
1
Age-Dependent Risk of Bronchial Asthma Exacerbation in Respiratory Syncytial Virus Co-infection.呼吸道合胞病毒合并感染时支气管哮喘发作的年龄依赖性风险
Lung. 2025 Sep 3;203(1):91. doi: 10.1007/s00408-025-00847-x.
2
Genetic and Immunological Profiling of Recent SARS-CoV-2 Omicron Subvariants: Insights into Immune Evasion and Infectivity in Monoinfections and Coinfections.新冠病毒奥密克戎变种新亚型的基因和免疫特征分析：单重感染和合并感染中免疫逃逸及传染性的见解
Viruses. 2025 Jun 27;17(7):918. doi: 10.3390/v17070918.
3
Colorectal Cancer Risk Following Herpes Zoster Reactivation in COVID-19 Survivors: Global Multicenter Study Using TriNetX.新冠病毒感染康复者带状疱疹再激活后的结直肠癌风险：使用TriNetX的全球多中心研究
Cancers (Basel). 2025 Jul 11;17(14):2306. doi: 10.3390/cancers17142306.
4
Co-infections during SARS-CoV-2 infection in hematologic patients and cell therapy recipients in the omicron era: a Spanish hematopoietic stem cell transplantation and cell therapy group study.奥密克戎时代血液学患者和细胞治疗接受者感染新型冠状病毒期间的合并感染：西班牙造血干细胞移植和细胞治疗组研究
BMC Infect Dis. 2025 Jul 25;25(1):944. doi: 10.1186/s12879-025-11302-w.
5
Evaluation of common respiratory viruses other than SARS-CoV-2 in hospitalized children during the COVID-19 pandemic.2019冠状病毒病大流行期间住院儿童中除严重急性呼吸综合征冠状病毒2之外的常见呼吸道病毒评估
BMC Infect Dis. 2025 Jul 11;25(1):910. doi: 10.1186/s12879-025-11293-8.
6
Prevalence of Viral and Bacterial Co-Infections in SARS-CoV-2-Positive Individuals in Cyprus 2020-2022.2020 - 2022年塞浦路斯新冠病毒检测呈阳性个体中病毒与细菌合并感染的患病率
Biomedicines. 2025 May 19;13(5):1236. doi: 10.3390/biomedicines13051236.
7
Pharmacological mechanisms of probenecid for SARS-CoV-2 and RSV co-infection: findings of system pharmacology, molecular docking, molecular dynamics simulation, and structure-activity relationship.丙磺舒治疗新型冠状病毒肺炎和呼吸道合胞病毒合并感染的药理机制：系统药理学、分子对接、分子动力学模拟及构效关系研究结果
Front Microbiol. 2025 Apr 30;16:1552603. doi: 10.3389/fmicb.2025.1552603. eCollection 2025.
8
EIDD-2801 resists to infection and co-infection of SARS-CoV-2 and influenza virus.EIDD-2801可抵抗严重急性呼吸综合征冠状病毒2（SARS-CoV-2）和流感病毒的感染及合并感染。
Virol J. 2025 Apr 28;22(1):126. doi: 10.1186/s12985-025-02755-1.
9
Point of Care Nucleic Acid Testing for Influenza-Like Illness: A Cost-Consequence Analysis for High-Risk Patients in Primary Care in Germany.流感样疾病的即时护理核酸检测：德国初级保健中高危患者的成本效益分析。
Adv Ther. 2025 May;42(5):2385-2402. doi: 10.1007/s12325-025-03156-0. Epub 2025 Mar 22.
10
Respiratory Viral Co-infection in SARS-CoV-2-Infected Children During the Early and Late Pandemic Periods.大流行早期和晚期感染SARS-CoV-2的儿童中的呼吸道病毒合并感染
Pediatr Infect Dis J. 2025 Apr 1;44(4):333-341. doi: 10.1097/INF.0000000000004623. Epub 2024 Nov 8.
本文引用的文献
1
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征：描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
Zotero 插件